Akebia Therapeutics News

Piper Sandler Sticks to Its Buy Rating for Akebia Therapeutics (AKBA)

TipRanksApr 26 19:50

Akebia Therapeutics Analyst Ratings

BenzingaMar 29 00:18

Analysts Offer Insights on Healthcare Companies: Integer Holdings (ITGR), Akebia Therapeutics (AKBA) and Moderna (MRNA)

TipRanksMar 28 19:00

Analysts' Top Healthcare Picks: Verastem (VSTM), Akebia Therapeutics (AKBA)

TipRanksMar 17 00:30

Akebia Therapeutics Analyst Ratings

BenzingaMar 15 18:25

HC Wainwright & Co. Reiterates Buy on Akebia Therapeutics, Maintains $5 Price Target

BenzingaMar 15 18:27

BTIG Assumes Akebia Therapeutics at Buy, Announces Price Target of $4

BenzingaNov 29, 2023 20:31

Akebia Therapeutics Analyst Ratings

BenzingaNov 29, 2023 20:30

Akebia Therapeutics Analyst Ratings

BenzingaNov 17, 2023 20:06

Analysts Are Bullish on These Healthcare Stocks: Sensei Biotherapeutics (SNSE), Akebia Therapeutics (AKBA)

TipRanksNov 17, 2023 19:31

Analysts Have Conflicting Sentiments on These Healthcare Companies: Akebia Therapeutics (AKBA), Teva Pharmaceutical (TEVA) and Quest Diagnostics (DGX)

TipRanksOct 25, 2023 19:02

Positive Prospects for Akebia Therapeutics: Buy Rating Upheld Amidst Drug Approval & Global Launch Preparations

TipRanksSep 27, 2023 19:03

HC Wainwright & Co. Reiterates Buy on Akebia Therapeutics, Maintains $3.75 Price Target

BenzingaSep 27, 2023 18:42

Akebia Therapeutics Analyst Ratings

BenzingaSep 27, 2023 18:41

Akebia Spikes as H.C. Wainwright Upgrades on Potential Vadadustat Approval

Seeking AlphaAug 28, 2023 22:04

HC Wainwright & Co. Upgrades Akebia Therapeutics to Buy, Raises Price Target to $3.75

BenzingaAug 28, 2023 18:30

Akebia Therapeutics Analyst Ratings

BenzingaAug 28, 2023 18:30

Akebia Therapeutics Analyst Ratings

BenzingaAug 11, 2023 18:50

H.C. Wainwright Reaffirms Their Hold Rating on Akebia Therapeutics (AKBA)

TipRanksAug 11, 2023 18:45

Akebia Therapeutics (AKBA) Gets a Buy From Piper Sandler

TipRanksJul 24, 2023 20:35